Sixth Street Partners Management Company »

Seres Therapeutics shares owned by Sixth Street Partners Management Company

Quarter-by-quarter ownership of Seres Therapeutics (MCRB) shares owned by Sixth Street Partners Management Company from 13F filings

Historical chart of Sixth Street Partners Management Company investment in Seres Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Seres Therapeutics held by Sixth Street Partners Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seres Therapeutics by Sixth Street Partners Management Company

Quarter filed Position value Share count Share price at filing
2026-06-30 $245k 31k 7.89

More positions owned by Sixth Street Partners Management Company

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Schwab Strategic Tr Fundamental Us L (FNDX)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
UnitedHealth (UNH)
Tesla Motors (TSLA)
Micron Technology (MU)
Schwab Strategic Tr Fundamental Intl (FNDF)
Eli Lilly & Co. (LLY)
Home Depot (HD)

View all positions for Sixth Street Partners Management Company

Top funds holding Seres Therapeutics

Flagship Ventures Management
Vanguard Capital Management
Marshall Wace
Susquehanna International
Vontobel Holding
BlackRock
Geode Capital Management
Citadel Advisors
Vanguard Fiduciary Trust
State Street Corporation
Lion Point Capital
Charles Schwab Investment Management
Sixth Street Partners Management Company
American Century Companies
Morgan Stanley

View all funds holding Seres Therapeutics